6
K. SUSUMU AND M. J. THERIEN
J = 6.9 Hz, –OC–CH2–), 1.49 (m, 2H, –CH2–), 1.2–1.4
(m, 16H, –CH2–), 0.88 (t, 3H, J = 6.7 Hz, –CH3). MS
(ESI): m/z 421.233 (calcd. for [M + H]+ 421.231).
4H, J = 6.4 Hz, –O–CH2–C), 3.94 (t, 8H, J = 7.5 Hz, –O–
CH2–C), 1.85 (quint, 4H, J = 7.0 Hz, –O–CH2–C), 1.50
(m, 4H, –CH2–), 1.15–1.40 (m, 32H, –CH2–), 0.89 (t, 6H,
–CH3), 0.85 (t, 8H, J = 7.5 Hz, –OC–CH2–), 0.39 (s, 36H,
–C–CH3). MS (MALDI-TOF): m/z 2076.99 (calcd. for
[M]+ 2076.857).
4-([4′-(4″-n-Dodecyloxyphenyl)benzo[c][1′,2′,5′]
thiadiazol-7′-yl]ethynyl)-7-iodobenzo[c][1,2,5]thiadia-
zole. 4-(4′-n-Dodecyloxyphenyl)-7-ethynylbenzo[c]
[1,2,5]thiadiazole (0.120 g, 2.85 × 10-4 mol), 4,7-diiodo-
benzo[c][1,2,5]thiadiazole [99] (0.232 g, 5.98 × 10-4 mol),
Pd2dba3 (32.8 mg, 3.6 × 10-5 mol), AsPh3 (92.4 mg, 3.0 ×
10-4 mol), and dry THF (15 mL) were added to a 100-mL
round-bottom flask. Ar was bubbled into the reaction
mixture for 5 min before diisopropylethylamine (1.0 mL)
was added. The reaction mixture was stirred at 48°C for
12.5 h underAr.After cooling, the solvent was evaporated.
The residue was chromatographed on silica gel with 8:1
hexanes:THF. The product was further purified by size
exclusion column chromatography (BioRad Bio-Beads
SX-1 packed in THF, gravity flow). Yield 69.8 mg
(36% based on 0.120 g of 4-(4′-n-dodecyloxyphenyl)-7-
ethynylbenzo[c][1,2,5]thiadiazole). 1H NMR (300 MHz;
CDCl3): d, ppm 8.16 (d, 1H, J = 7.5 Hz, Ph-H), 8.03 (d,
1H, J = 7.4 Hz, Ph-H), 7.96 (d, 2H, J = 8.9 Hz, Ph-H), 7.71
(d, 1H, J = 7.4 Hz, Ph-H), 7.70 (d, 1H, J = 7.5 Hz, Ph-H),
7.08 (d, 2H, J = 8.9 Hz, Ph-H), 4.05 (t, 2H, J = 6.5 Hz,
–OCH2–), 1.84 (quint, 2H, J = 7.0 Hz, –OC–CH2–),
1.49 (m, 2H, –CH2–), 1.2–1.4 (m, 16H, –CH2–), 0.88 (t,
3H, J = 6.6 Hz, –CH3). MS (MALDI-TOF): m/z 680.09
(calcd. for [M]+ 680.110).
5,15-Bis([7′-(4′′-N,N-dihexylaminophenylethynyl)
benzo[c][1′,2′,5′]thiadiazol-4′-yl]ethynyl)-10,20-
bis[2′,6′-bis(3′′,3′′-dimethyl-1′′-butyloxy)phenyl]
porphinato)zinc(II) (8). 4-(4′-N,N-Dihexylamino-
phenylethynyl)-7-iodobenzo[c][1,2,5]thiadiazole [99]
(73.6 mg,1.35×10-4 mol),5,15-diethynyl-10,20-bis[2′,6′-
bis(3′′,3′′-dimethyl-1′′-butyloxy)phenyl]porphinato)
zinc(II) (59.0 mg, 6.05 × 10-5 mol), Pd(PPh3)4 (15.6 mg,
1.35 × 10-5 mol), CuI (1.0 mg, 5.3 × 10-6 mol), and dry
THF (6.0 mL) were added to a 100-mL round-bottom
flask. Ar was bubbled into the reaction mixture for 5 min
before piperidine (0.50 mL) was added. The reaction
mixture was stirred at 49°C for 20 h under Ar. After
cooling, the solvent was evaporated. The residue was
chromatographed on silica gel with 5:1 hexanes:THF
as the eluent. The product was further purified by size
exclusion column chromatography (BioRad Bio-Beads
SX-1 packed in THF, gravity flow). Yield 0.107 g (98%
based on 59.0 mg of 5,15-diethynyl-10,20-bis[2′,6′-
bis(3′′,3′′-dimethyl-1′′-butyloxy)phenyl]porphinato)
1
zinc(II)). H NMR (300 MHz; CDCl3): d, ppm 9.99 (d,
4H, J = 4.6 Hz, b-H), 8.94 (d, 4H, J = 4.6 Hz, b-H), 8.17
(d, 2H, J = 7.4 Hz, Ph-H), 7.89 (d, 2H, J = 7.4 Hz, Ph-H),
7.73 (t, 2H, J = 8.4 Hz, Ph-H), 7.56 (d, 4H, J = 7.7 Hz,
Ph-H), 7.03 (d, 4H, J = 8.5 Hz, Ph-H), 6.64 (d, 4H, J =
9.0 Hz, Ph-H), 3.94 (t, 8H, J = 7.3 Hz, –O–CH2–C), 3.32
(t, 8H, J = 7.6 Hz, –N–CH2–C), 1.5–1.7 (m, 4H, –CH2–),
1.25–1.45 (m, 24H, –CH2–), 0.8–1.0 (m, 20H, –O–C–
CH2– and –CH3), 0.26 (s, 36H, –C–CH3). MS (MALDI-
TOF): m/z 1807.1 (calcd. for [M]+ 1806.901).
(5,15-Bis([7′-([7″-(4′″-n-dodecyloxyphenyl)benzo
[c][1″,2″,5″]thiadiazol-4″-yl]ethynyl)benzo[c]-
[1′,2′,5′]thiadiazol-4′-yl]ethynyl)-10,20-bis[2′,6′-
bis(3″,3″-dimethyl-1″-butyloxy)phenyl]porphinato)
zinc(II) (7). 4-([4′-(4″-n-Dodecyloxyphenyl)benzo[c]
[1′,2′,5′]thiadiazol-7′-yl]ethynyl)-7-iodobenzo[c][1,2,5]
thiadiazole (31.0 mg, 4.55 × 10-5 mol), 5,15-diethynyl-
10,20-bis[2′,6′-bis(3″,3″-dimethyl-1″-butyloxy)
phenyl]porphinato)zinc(II) (22.2 mg, 2.28 × 10-5 mol),
Pd(PPh3)4 (9.1 mg, 7.9 × 10-6 mol), CuI (1.7 mg, 8.9 ×
10-6 mol), and dry THF (8.0 mL) were added to a
100-mL round-bottom flask. Ar was bubbled into the
reaction mixture for 5 min before piperidine (0.50 mL)
was added. The reaction mixture was stirred at 50°C
for 3.5 h under Ar. After cooling, the solvent was
evaporated. The residue was chromatographed on
silica gel with 3:1 hexanes:THF as the eluent. The
product was further purified by size exclusion column
chromatography (BioRad Bio-Beads SX-1 packed
in THF, gravity flow). Yield 30.2 mg (64% based on
31.0 mg of 4-([4′-(4′′-n-dodecyloxyphenyl)benzo[c]
[1′,2′,5′]thiadiazol-7′-yl]ethynyl)-7-iodobenzo[c][1,2,5]
4-(4′-(N,N-Dihexylamino)phenylethenyl)-7-iodo-
benzo[c][1,2,5]thiadiazole. N,N-Dihexylamino-4-vinyl-
benzene[99](0.154g,5.36×10-4 mol),4,7-diiodobenzo[c]
[1,2,5]thiadiazole [99] (0.309 g, 7.96 × 10-4 mol),
Pd2dba3 (50.4 mg, 5.5 × 10-5 mol), and dry 1,4-dioxane
(7.0 mL) were added to a 100-mL round-bottom flask.
Ar was bubbled into the reaction mixture for 5 min
before dicyclohexylmethylamine (0.50 mL) and P(t-Bu)3
(10 wt% in hexanes, 1.00 mL, 3.3 × 10-4 mol) were
added. The reaction mixture was stirred at 57°C for 48 h
under Ar. After the solvent was evaporated, the reaction
mixture was chromatographed on silica gel with 8:1
hexanes:THF. The product was further purified by size
exclusion column chromatography (BioRad Bio-Beads
SX-1 packed in THF, gravity flow). Yield 42.2 mg (14%
based on 0.154 g of N,N-dihexylamino-4-vinylbenzene).
1H NMR (300 MHz; CDCl3): d, ppm 8.04 (d, 1H, J = 7.6
Hz, Ph-H), 7.84 (d, 1H, J = 16.4 Hz, vinyl-H), 7.50 (d,
2H, J = 8.8 Hz, Ph-H), 7.38 (d, 1H, J = 16.2 Hz, vinyl-H),
7.37 (d, 1H, J = 7.8 Hz, Ph-H), 6.64 (d, 2H, J = 8.9 Hz,
Ph-H), 3.30 (t, 4H, J = 7.6 Hz, –NCH2–), 1.61 (m, 4H,
1
thiadiazole). H NMR (300 MHz; 1 drop pyridine-d5 in
CDCl3): d, ppm 9.92 (d, 4H, J = 4.6 Hz, b-H), 8.89 (d,
4H, J = 4.5 Hz, b-H), 8.21 (d, 2H, J = 7.4 Hz, Ph-H), 8.13
(d, 2H, J = 7.4 Hz, Ph-H), 8.09 (d, 2H, J = 7.4 Hz, Ph-H),
7.98 (d, 4H, J = 8.7 Hz, Ph-H), 7.75 (d, 2H, J = 7.3 Hz,
Ph-H), 7.73 (t, 2H, J = 8.3 Hz, Ph-H), 7.09 (d, 4H, J =
8.8 Hz, Ph-H), 7.04 (d, 4H, J = 8.5 Hz, Ph-H), 4.06 (t,
Copyright © 2014 World Scientific Publishing Company
J. Porphyrins Phthalocyanines 2014; 18: 6–14